SRx Financial Statements From 2010 to 2026

SRXH Stock   0.24  0.01  3.43%   
SRx Health's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing SRx Health's valuation are provided below:
Gross Profit
32.1 M
Profit Margin
(0.09)
Market Capitalization
6.4 M
Revenue
161.5 M
Quarterly Revenue Growth
(0.09)
We have found one hundred twenty available fundamental trend indicators for SRx Health Solutions, which can be analyzed and compared to other ratios and to its competition. Traders should compare all of SRx Health Solutions current fundamentals against the fundamentals between 2010 and 2026 to make sure the company is sustainable this year. The current Market Cap is estimated to decrease to about 809.3 K. The SRx Health's current Enterprise Value is estimated to increase to about (15.1 M)

SRx Health Total Revenue

5.59 Million

Check SRx Health financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among SRx Health's main balance sheet or income statement drivers, such as Depreciation And Amortization of 111.2 K, Interest Expense of 536.9 K or Total Revenue of 5.6 M, as well as many indicators such as Price To Sales Ratio of 0.0176, Dividend Yield of 0.0 or PTB Ratio of 0.0197. SRx financial statements analysis is a perfect complement when working with SRx Health Valuation or Volatility modules.
  
Build AI portfolio with SRx Stock
Check out the analysis of SRx Health Correlation against competitors.

SRx Health Balance Sheet

Current ValueLast YearHistorical Average 10 Year Trend
Total Assets7.2 M7.6 M42.8 M
Slightly volatile
Short and Long Term Debt Total32.1 M52.1 M33.6 M
Pretty Stable
Total Current LiabilitiesM3.2 M38.7 M
Slightly volatile
Property Plant And Equipment Net118 K124.2 K2.2 M
Slightly volatile
Current Deferred Revenue24.8 K26.1 K228.9 K
Slightly volatile
Accounts Payable2.3 M2.5 M7.1 M
Slightly volatile
Cash1.1 M1.2 M4.7 M
Very volatile
Non Current Assets Total236 K248.4 K25.4 M
Slightly volatile
Cash And Short Term Investments2.6 M2.8 M4.9 M
Very volatile
Net Receivables6.2 M4.5 M5.1 M
Slightly volatile
Good Will346.3 K364.5 K13.7 M
Slightly volatile
Common Stock Shares Outstanding30.1 M28.7 M5.9 M
Slightly volatile
Liabilities And Stockholders Equity13.5 M14.2 M44 M
Slightly volatile
Non Current Liabilities Total3.8 MM17.5 M
Slightly volatile
Inventory3.4 M1.9 M4.4 M
Slightly volatile
Other Current Assets678.9 K714.6 K3.7 M
Slightly volatile
Total Liabilities6.8 M7.2 M55.7 M
Slightly volatile
Total Current Assets6.9 M7.3 M17.5 M
Pretty Stable
Short Term Debt47.1 M44.8 M17.4 M
Slightly volatile
Intangible Assets7.2 M6.3 M10.8 M
Slightly volatile
Common Stock24 K25.3 K983.1 K
Pretty Stable
Long Term Debt2.8 M5.1 M1.3 M
Slightly volatile
Capital Lease Obligations18 K18.9 K5.8 M
Slightly volatile
Property Plant And Equipment Gross478.8 K504 K14.7 M
Slightly volatile
Short and Long Term Debt30 M33.8 M36.9 M
Slightly volatile
Capital Stock29.1 K35.6 K23.8 K
Slightly volatile

SRx Health Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization111.2 K117 K1.3 M
Slightly volatile
Interest Expense536.9 K565.2 K5.9 M
Slightly volatile
Total Revenue5.6 M5.9 M43.3 M
Pretty Stable
Gross Profit1.3 M1.4 M12.4 M
Slightly volatile
Other Operating Expenses86.4 M47.1 M70.4 M
Very volatile
Cost Of Revenue4.3 M4.5 M30.9 M
Very volatile
Total Operating Expenses20.4 M16.1 M33.2 M
Slightly volatile
Income Tax Expense7.7 K8.1 K63.4 K
Pretty Stable
Selling And Marketing Expenses2.4 M2.7 M2.9 M
Slightly volatile
Research Development80 K90 K98.2 K
Slightly volatile
Reconciled Depreciation26.5 K27.9 K3.6 M
Slightly volatile

SRx Health Cash Flow Statement

Current ValueLast YearHistorical Average 10 Year Trend
Begin Period Cash Flow90.6 K95.4 K3.8 M
Very volatile
Depreciation33.9 K35.6 K1.6 M
Pretty Stable
Total Cash From Financing Activities11.2 M11 M11.1 M
Pretty Stable
End Period Cash Flow1.1 M1.2 M4.7 M
Very volatile
Stock Based Compensation3.6 M3.7 M3.1 M
Slightly volatile
Net Borrowings2.4 M4.2 M1.2 M
Slightly volatile

Financial Ratios

Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio0.01760.01850.0329
Slightly volatile
Days Sales Outstanding33.548.527.3579
Slightly volatile
Average Payables11.2 M17.1 M11.4 M
Slightly volatile
Stock Based Compensation To Revenue0.05180.09440.0399
Slightly volatile
Capex To Depreciation0.150.190.1848
Very volatile
Inventory Turnover8.795.5414.896
Slightly volatile
Days Of Inventory On Hand47.9968.1632.9339
Slightly volatile
Payables Turnover5.818.165.8836
Very volatile
Sales General And Administrative To Revenue0.140.20.1595
Slightly volatile
Average InventoryM5.2 M4.7 M
Slightly volatile
Research And Ddevelopement To Revenue0.00230.00260.0028
Slightly volatile
Capex To Revenue0.00570.00880.0042
Slightly volatile
Cash Per Share77.1673.4919.1489
Slightly volatile
Days Payables Outstanding43.9946.394.6851
Pretty Stable
Intangibles To Total Assets0.50.450.4025
Slightly volatile
Current Ratio7.226.882.0933
Slightly volatile
Receivables Turnover10.366.119.685
Slightly volatile
Capex Per Share0.450.90.4308
Slightly volatile
Average ReceivablesM6.7 M5.6 M
Slightly volatile
Revenue Per Share109117118
Slightly volatile
Interest Debt Per Share32.6834.438.2255
Pretty Stable
Debt To Assets0.110.120.5735
Very volatile
Graham Number110124135
Slightly volatile
Operating Cycle94.0513061.823
Slightly volatile
Days Of Payables Outstanding43.9946.394.6851
Pretty Stable
Quick Ratio6.366.061.7651
Slightly volatile
Net Income Per E B T0.830.781.1081
Slightly volatile
Cash Ratio4.764.531.086
Slightly volatile
Days Of Inventory Outstanding47.9968.1632.9339
Slightly volatile
Days Of Sales Outstanding33.548.527.3579
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio1.01.180.947
Pretty Stable
Fixed Asset Turnover13112440.1698
Slightly volatile
Debt Ratio0.110.120.5735
Very volatile
Price Sales Ratio0.01760.01850.0329
Slightly volatile
Asset Turnover0.510.531.9851
Slightly volatile
Gross Profit Margin0.30.340.2103
Slightly volatile

SRx Health Valuation Data

Current ValueLast YearHistorical Average 10 Year Trend
Market Cap809.3 K851.9 K2.8 M
Pretty Stable

About SRx Health Financial Statements

Investors use fundamental indicators, such as SRx Health's revenue or net income, to determine how well the company is positioned to perform in the future. Although SRx Health's investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
Last ReportedProjected for Next Year
Current Deferred Revenue26.1 K24.8 K
Total Revenue5.9 M5.6 M
Cost Of Revenue4.5 M4.3 M
Stock Based Compensation To Revenue 0.09  0.05 
Sales General And Administrative To Revenue 0.20  0.14 
Capex To Revenue 0.01  0.01 
Revenue Per Share 116.82  108.56 
Ebit Per Revenue(0.34)(0.35)

Currently Active Assets on Macroaxis

When determining whether SRx Health Solutions offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of SRx Health's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Srx Health Solutions Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Srx Health Solutions Stock:
Check out the analysis of SRx Health Correlation against competitors.
You can also try the Top Crypto Exchanges module to search and analyze digital assets across top global cryptocurrency exchanges.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of SRx Health. If investors know SRx will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about SRx Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Revenue Per Share
13.04
Quarterly Revenue Growth
(0.09)
Return On Assets
(0.11)
The market value of SRx Health Solutions is measured differently than its book value, which is the value of SRx that is recorded on the company's balance sheet. Investors also form their own opinion of SRx Health's value that differs from its market value or its book value, called intrinsic value, which is SRx Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because SRx Health's market value can be influenced by many factors that don't directly affect SRx Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between SRx Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if SRx Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, SRx Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.